David Tepper
Appaloosa Management
David Tepper HCA Healthcare, Inc stake
total: 317
Appaloosa Management HCA trades
- Total transactions:
- 33
- New positions:
- 4
- Sold out:
- 4
- Added:
- 10
- Reduced:
- 15
- Held since:
- 2023 Q4
- Held for:
- 1 quarter
- Latest activity:
- 2024 Q1
According to 2026 Q2 report, David Tepper doesn't hold any HCA Healthcare, Inc (HCA) shares. Appaloosa Management has held HCA since at least 2013 Q2 with about 3.92M shares in our earliest available record. David Tepper later completely sold out the position and invested in HCA Healthcare, Inc again in 2023 Q4. Since at least 2013 Q2, Appaloosa Management has made 32 more transactions.
When did David Tepper sell HCA Healthcare, Inc (HCA)?
David Tepper sold off the entire HCA Healthcare, Inc (HCA) position in 2024 Q1.
Estimated cost basis*
- Weighted AVG buy price:
- $270.68
- Weighted AVG sell price:
- $270.68
David Tepper's historical trades in HCA Healthcare, Inc
33 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2024 Q1
|
0.00%
|
0
|
$270.68
|
|
-100% (-117,198)
|
-0.56%
|
|
2023 Q4
|
0.56%
|
117,198
|
$270.68
|
$31,723,155
|
new
|
+0.56%
|
|
2023 Q2
|
0.00%
|
0
|
$263.68
|
|
-100% (-142,500)
|
-2.03%
|
|
2023 Q1
|
2.03%
|
142,500
|
$263.68
|
$37,574,400
|
-21.92% (-40,000)
|
-0.78%
|
|
2022 Q4
|
3.25%
|
182,500
|
$239.96
|
$43,792,700
|
+143.33% (+107,500)
|
+1.91%
|
|
2022 Q2
|
0.79%
|
75,000
|
$168.07
|
$12,605,000
|
new
|
+0.79%
|
|
2021 Q4
|
0.00%
|
0
|
$242.72
|
|
-100% (-387,000)
|
-2.24%
|
|
2021 Q3
|
2.24%
|
387,000
|
$242.72
|
$93,933,000
|
-4.44% (-18,000)
|
-0.09%
|
|
2021 Q2
|
1.73%
|
405,000
|
$206.74
|
$83,730,000
|
-57.37% (-545,000)
|
-1.62%
|
|
2021 Q1
|
2.57%
|
950,000
|
$188.34
|
$178,923,000
|
-5.00% (-50,000)
|
-0.14%
|
|
2020 Q4
|
2.46%
|
$164.46
|
+6.95% (+65,000)
|
|||
|
2020 Q3
|
2.06%
|
$124.68
|
-10.95% (-115,000)
|
|||
|
2020 Q2
|
1.77%
|
$97.06
|
+268.42% (+765,000)
|
|||
|
2020 Q1
|
0.78%
|
$89.85
|
new
|
|||
|
2018 Q2
|
0.00%
|
$97.00
|
-100% (-282,884)
|
|||
|
2018 Q1
|
0.28%
|
$97.00
|
-48.83% (-270,000)
|
|||
|
2017 Q4
|
0.46%
|
$87.84
|
+200.95% (+369,173)
|
|||
|
2017 Q3
|
0.21%
|
$79.59
|
+9.54% (+16,000)
|
|||
|
2017 Q2
|
0.22%
|
$87.20
|
-65.61% (-320,000)
|
|||
|
2017 Q1
|
0.76%
|
$88.99
|
-57.41% (-657,539)
|
|||
|
2016 Q4
|
1.57%
|
$74.02
|
-7.41% (-91,690)
|
|||
|
2016 Q3
|
2.42%
|
$75.63
|
+1.64% (+20,000)
|
|||
|
2016 Q2
|
2.46%
|
$77.01
|
-61.65% (-1,956,483)
|
|||
|
2016 Q1
|
4.96%
|
$78.05
|
-30.06% (-1,363,640)
|
|||
|
2015 Q4
|
6.97%
|
$67.63
|
+27.68% (+983,526)
|
|||
|
2015 Q3
|
9.75%
|
$77.36
|
-15.08% (-630,988)
|
|||
|
2015 Q2
|
9.40%
|
$90.72
|
-14.72% (-722,057)
|
|||
|
2015 Q1
|
8.75%
|
$75.23
|
-2.08% (-104,000)
|
|||
|
2014 Q4
|
9.08%
|
$73.39
|
-5.94% (-316,300)
|
|||
|
2014 Q1
|
3.73%
|
$52.50
|
+4.42% (+225,500)
|
|||
|
2013 Q4
|
3.05%
|
$47.71
|
+11.55% (+528,300)
|
|||
|
2013 Q3
|
3.14%
|
$42.75
|
+16.57% (+650,000)
|
|||
|
2013 Q2
|
2.05%
|
$36.06
|
new or own*
|
|||
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.